TH1701005921A - Substances used to treat dry eye syndrome Which includes the nandrolone or esters of this Or methinolone, or esters of this As an active ingredient - Google Patents

Substances used to treat dry eye syndrome Which includes the nandrolone or esters of this Or methinolone, or esters of this As an active ingredient

Info

Publication number
TH1701005921A
TH1701005921A TH1701005921A TH1701005921A TH1701005921A TH 1701005921 A TH1701005921 A TH 1701005921A TH 1701005921 A TH1701005921 A TH 1701005921A TH 1701005921 A TH1701005921 A TH 1701005921A TH 1701005921 A TH1701005921 A TH 1701005921A
Authority
TH
Thailand
Prior art keywords
esters
methinolone
nandrolone
active ingredient
dry eye
Prior art date
Application number
TH1701005921A
Other languages
Thai (th)
Inventor
เอ็นโดะ
เคนอิจิ
ฟูจิอิ ชิโนบุ
โอกิ เคนจิ
Original Assignee
นางดารานีย์ วัจนะวุฒิวงศ์
นางสาวสนธยา สังขพงศ์
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงศ์, นางสาวสนธยา สังขพงศ์ filed Critical นางดารานีย์ วัจนะวุฒิวงศ์
Publication of TH1701005921A publication Critical patent/TH1701005921A/en

Links

Claims (1)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แก้ไข 16/12/2562 ไม่มีข้อถือสิทธิ ---------------------------- แก้ไข 31 พ.ค. 2562 หน้า 1 ของจำนวน 4 หน้า แท็ก : สิทธิบัตรยา: Claims (number one) which will appear on the advertisement notice page: edit 16/12/2019 No disclaimers ---------------------------- Revised May 31, 2019 Page 1 of the number 4 pages Tag: drug patent
TH1701005921A 2016-04-01 Substances used to treat dry eye syndrome Which includes the nandrolone or esters of this Or methinolone, or esters of this As an active ingredient TH1701005921A (en)

Publications (1)

Publication Number Publication Date
TH1701005921A true TH1701005921A (en) 2019-12-23

Family

ID=

Similar Documents

Publication Publication Date Title
TH1701005921A (en) Substances used to treat dry eye syndrome Which includes the nandrolone or esters of this Or methinolone, or esters of this As an active ingredient
TH1701007535A (en) Preparation of 2,5,6-trihydroxy-3-hexenoic acid and 2,5-dihydroxy-3-pentenoic acid. And the ester of that from sugars C6 and C5.
TH1701004077A (en) Active substance for improving early insulin secretion capacity.
TH180207A (en) Improved stability of glucagon derivatives (GLUCAGON DERIVATIVES).
TH1701003244A (en) Piperidine derivatives as an inhibitor of HDAC1 / 2
TH180976A (en) Diheterocycle derivative is connected - cycloalkyl.
TH1601006837A (en) Compounds for the treatment of spinal cord atrophy
TH1701004168A (en) Elements that can be dispersed
TH176338A (en) Composition for the suspension of phosphorus absorption.
TH1701001069A (en) Tetrahydro-naphthalene derivatives that inhibit MCL-1 protein.
TH1701007724A (en)
TH75219S1 (en) Diaper pants
TH1701003631A (en) Quinazoline derivatives used to treat HIV
TH1701001929A (en) Substitudate aminopureine compounds, their constituents, and their treatment methods
TH1701007762A (en) 2,3-dihydro-4H-1,3-benzoxacin-4-transfer derivative. The muscharinic M1 receptor is the controller of the Colinergic.
TH1501005024A (en) Pharmaceutical constituents for the treatment of fungal infections.
TH1701004149A (en) Skin care products containing HERMETIA ILLUCENS extract
TH178967A (en) Fuel elements that include humin
TH178047A (en) 2- thioimidazolid carboxamide replaced as pesticides
TH1601003241A (en) Use of benzimidazole-proline derivatives
TH66560B (en) Acaindole derivatives
TH1701002032A (en) The use of neridronic acid or its salts for the treatment of osteomyelitis.
TH1701005228A (en) Kv1.3 inhibitors and their medical applications
TH173918A (en) Triazole compounds
TH178555A (en) Heteroerril derivatives Or its pharmaceutical acceptable salt, method of preparation, and pharmaceutical constituents for the prevention or treatment of disease. Associated with PI3 kinase, which has the same thing as active ingredient.